Lisa Cox is an accomplished executive with extensive experience in health economics and outcomes research (HEOR) and market access. Currently serving as Executive Director of HEOR and Access at FIECON since January 2024, Lisa previously held the position of Vice President and Head of HEOR & HTA Strategy at Lumanity, where responsibilities included team leadership and integration, managed a team of 15, and enhanced service offerings for clients. Prior to Lumanity, Lisa spent eight years at BresMed, advancing from Senior Business Manager to Business Unit Head roles, where leadership and team culture initiatives contributed to strong retention rates and business growth. Lisa's career also includes significant roles at Hayward Medical Communications and Learning Plus UK, supported by a Bachelor of Science degree in Human Biology from Loughborough University.
Org chart
Teams
This person is not in any teams
Offices
This person is not in any offices
FIECON
FIECON was born out of the desire to make a difference in the world we live in – harnessing the power of health economics for the good of humanity. To date, we have donated over £900,000 to charitable causes. Our services: We provide services across the life cycle of a product and have worked in countries across the globe. Our key service areas comprise: • Outcomes Research • Economic Modelling • Health Technology Assessment • Value Communication • Pricing & Reimbursement Our products: We challenge the conventional and think outside the box to provide game-changing, innovative products that meet your commercial needs. Our products include: • FIECON Model Builder • FIECON Value Platform • FIECON Modelling Center powered by FIECON Model Builder Our vision is to use economics for the good of humanity. We do this by making a positive difference in the lives of our people, our clients, and our society. Our core values guide our day-to-day actions and make FIECON a great place to work: * Learn, Grow, and Flourish Together * Deliver Results and Delight Clients * Improve Lives and Build a Better World Our ultimate aspiration is to set the bar for how workplaces operate, and by 2030 we aim to achieve a number of goals: We want to test the hypothesis that you can maintain a great culture as you grow, achieving external certification through the Great Place to Work award. We want to show that we have affected millions of lives – 100M in fact – which we can quantify based on the drugs we take to market each year. We want to give back BIG both in terms of our time and donations – £10M since our founding is the first stake in the ground. We also want to demonstrate that we are meeting the highest standards for social responsibility by achieving B-Corp status. hello@fiecon.com
Industries
Employees
51-200
